Wu Rongqian, Zhou Mian, Cui Xiaoxuan, Simms H Hank, Wang Ping
Division of Surgical Research, Department of Surgery, North Shore-Long Island Jewish Medical Center and New York University School of Medicine, Manhasset, NY 11030, USA.
Int J Mol Med. 2003 Nov;12(5):777-81.
The cardiovascular response to sepsis is characterized by an early, hyperdynamic phase followed by a late, hypodynamic phase. Ghrelin, a newly-identified endogenous ligand for growth hormone secretagogue receptor (i.e., ghrelin receptor), was recently demonstrated to be a potent vasoactive peptide in addition to its effects on growth hormone release and energy homeostasis. We have shown that ghrelin (via its receptor) may play an important role in regulating cardiovascular responses in the progression of polymicrobial sepsis. However, it remains unknown whether the clearance of this peptide is altered in sepsis. To determine this, male adult rats were injected with 125I-ghrelin through the jugular vein at 5 or 20 h after cecal ligation and puncture (CLP, i.e., sepsis model) or sham operation. The blood sample was collected every 2 min for 30 min for determining half-life (t1/2). Tissue samples (i.e., kidneys, liver, brain, heart, lungs, spleen, stomach, small intestine, large intestine, skin and muscle) were then harvested. The radioactivities of samples were counted. The results indicate that 125I-ghrelin's t1/2 and its distribution were not significantly altered in early sepsis (5 h after CLP). However, the t1/2 increased significantly in late sepsis (20 h after CLP). Tissue distribution of 125I-ghrelin was far greater in the kidneys than in any other tissues tested in both sham and septic animals. Moreover, the kidneys and liver had significantly less radioactive uptake at 20 h after CLP, but the radioactivity in blood was much higher at the same time point. There were no significant changes in 125I-ghrelin distribution in other organs at the late stage of sepsis. These results indicate that the kidneys are the primary site of ghrelin clearance, which is significantly diminished in late sepsis. In addition, the liver also plays a role in the clearance of ghrelin, which was also reduced in late sepsis. The decreased clearance of ghrelin by the kidneys and liver may be due to renal and hepatic dysfunctions under such conditions.
脓毒症时的心血管反应特征为早期的高动力相和随后的低动力相。胃饥饿素是一种新发现的生长激素促分泌素受体(即胃饥饿素受体)的内源性配体,最近研究表明,它除了对生长激素释放和能量平衡有影响外,还是一种强效血管活性肽。我们已经证明,胃饥饿素(通过其受体)可能在调节多微生物脓毒症进展过程中的心血管反应中发挥重要作用。然而,脓毒症时这种肽的清除是否发生改变仍不清楚。为了确定这一点,在盲肠结扎和穿刺(CLP,即脓毒症模型)或假手术后5小时或20小时,通过颈静脉给成年雄性大鼠注射125I标记的胃饥饿素。每隔2分钟采集一次血样,共采集30分钟以测定半衰期(t1/2)。然后采集组织样本(即肾脏、肝脏、脑、心脏、肺、脾脏、胃、小肠、大肠、皮肤和肌肉)。对样本的放射性进行计数。结果表明,在脓毒症早期(CLP后5小时),125I标记的胃饥饿素的t1/2及其分布没有显著改变。然而,在脓毒症晚期(CLP后20小时),t1/2显著增加。在假手术组和脓毒症组动物中,125I标记的胃饥饿素在肾脏中的组织分布远远高于其他任何测试组织。此外,CLP后20小时,肾脏和肝脏的放射性摄取显著减少,但同一时间点血液中的放射性则高得多。在脓毒症晚期,其他器官中125I标记的胃饥饿素分布没有显著变化。这些结果表明,肾脏是胃饥饿素清除的主要部位,在脓毒症晚期其清除能力显著降低。此外,肝脏也参与胃饥饿素的清除,在脓毒症晚期其清除能力也降低。在这种情况下,肾脏和肝脏对胃饥饿素清除能力的降低可能是由于肾和肝功能障碍所致。